Psyence Biomedical Ltd is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Psyence Biomedical Ltd 주요 수익원은 Offline Sales to Dealers이며, 최신 수익 발표에서 수익은 84,894,000입니다. 지역별로는 North America이 Psyence Biomedical Ltd의 주요 시장이며, 수익은 89,662,000입니다.
Psyence Biomedical Ltd은 수익성이 있나요?
예, 최신 재무제표에 따르면 Psyence Biomedical Ltd의 순이익은 $8입니다.